Expression screening of 17q12-21 amplicon reveals GRB7 as an ERBB2-dependent oncogene

Makoto Saito, Yukiko Kato, Emi Ito, Jiro Fujimoto, Kosuke Ishikawa, Ayano Doi, Kentaro Kumazawa, Atsuka Matsui, Shiori Takebe, Takaomi Ishida, Sakura Azuma, Hiromi Mochizuki, Yoshifumi Kawamura, Yuka Yanagisawa, Reiko Honma, Jun Ichi Imai, Hirokazu Ohbayashi, Naoki Goshima, Kentaro Senba, Shinya Watanabe

    Research output: Contribution to journalArticle

    14 Citations (Scopus)

    Abstract

    Gene amplification is a major genetic alteration in human cancers. Amplicons, amplified genomic regions, are believed to contain "driver" genes responsible for tumorigenesis. However, the significance of co-amplified genes has not been extensively studied. We have established an integrated analysis system of amplicons using retrovirus-mediated gene transfer coupled with a human full-length cDNA set. Applying this system to 17q12-21 amplicon observed in breast cancer, we identified GRB7 as a context-dependent oncogene, which modulates the ERBB2 signaling pathway through enhanced phosphorylation of ERBB2 and Akt. Our work provides an insight into the biological significance of gene amplification in human cancers.

    Original languageEnglish
    Pages (from-to)1708-1714
    Number of pages7
    JournalFEBS Letters
    Volume586
    Issue number12
    DOIs
    Publication statusPublished - 2012 Jun 12

    Fingerprint

    Oncogenes
    Screening
    Gene Amplification
    Genes
    Gene transfer
    Phosphorylation
    Complementary DNA
    Retroviridae
    Neoplasms
    Carcinogenesis
    Breast Neoplasms

    Keywords

    • ERBB2
    • Expression screening
    • Gene amplification
    • GRB7
    • Tumorigenesis

    ASJC Scopus subject areas

    • Biochemistry
    • Biophysics
    • Cell Biology
    • Genetics
    • Molecular Biology
    • Structural Biology

    Cite this

    Saito, M., Kato, Y., Ito, E., Fujimoto, J., Ishikawa, K., Doi, A., ... Watanabe, S. (2012). Expression screening of 17q12-21 amplicon reveals GRB7 as an ERBB2-dependent oncogene. FEBS Letters, 586(12), 1708-1714. https://doi.org/10.1016/j.febslet.2012.05.003

    Expression screening of 17q12-21 amplicon reveals GRB7 as an ERBB2-dependent oncogene. / Saito, Makoto; Kato, Yukiko; Ito, Emi; Fujimoto, Jiro; Ishikawa, Kosuke; Doi, Ayano; Kumazawa, Kentaro; Matsui, Atsuka; Takebe, Shiori; Ishida, Takaomi; Azuma, Sakura; Mochizuki, Hiromi; Kawamura, Yoshifumi; Yanagisawa, Yuka; Honma, Reiko; Imai, Jun Ichi; Ohbayashi, Hirokazu; Goshima, Naoki; Senba, Kentaro; Watanabe, Shinya.

    In: FEBS Letters, Vol. 586, No. 12, 12.06.2012, p. 1708-1714.

    Research output: Contribution to journalArticle

    Saito, M, Kato, Y, Ito, E, Fujimoto, J, Ishikawa, K, Doi, A, Kumazawa, K, Matsui, A, Takebe, S, Ishida, T, Azuma, S, Mochizuki, H, Kawamura, Y, Yanagisawa, Y, Honma, R, Imai, JI, Ohbayashi, H, Goshima, N, Senba, K & Watanabe, S 2012, 'Expression screening of 17q12-21 amplicon reveals GRB7 as an ERBB2-dependent oncogene', FEBS Letters, vol. 586, no. 12, pp. 1708-1714. https://doi.org/10.1016/j.febslet.2012.05.003
    Saito M, Kato Y, Ito E, Fujimoto J, Ishikawa K, Doi A et al. Expression screening of 17q12-21 amplicon reveals GRB7 as an ERBB2-dependent oncogene. FEBS Letters. 2012 Jun 12;586(12):1708-1714. https://doi.org/10.1016/j.febslet.2012.05.003
    Saito, Makoto ; Kato, Yukiko ; Ito, Emi ; Fujimoto, Jiro ; Ishikawa, Kosuke ; Doi, Ayano ; Kumazawa, Kentaro ; Matsui, Atsuka ; Takebe, Shiori ; Ishida, Takaomi ; Azuma, Sakura ; Mochizuki, Hiromi ; Kawamura, Yoshifumi ; Yanagisawa, Yuka ; Honma, Reiko ; Imai, Jun Ichi ; Ohbayashi, Hirokazu ; Goshima, Naoki ; Senba, Kentaro ; Watanabe, Shinya. / Expression screening of 17q12-21 amplicon reveals GRB7 as an ERBB2-dependent oncogene. In: FEBS Letters. 2012 ; Vol. 586, No. 12. pp. 1708-1714.
    @article{611356c3e2b84fcda40d963febd2f234,
    title = "Expression screening of 17q12-21 amplicon reveals GRB7 as an ERBB2-dependent oncogene",
    abstract = "Gene amplification is a major genetic alteration in human cancers. Amplicons, amplified genomic regions, are believed to contain {"}driver{"} genes responsible for tumorigenesis. However, the significance of co-amplified genes has not been extensively studied. We have established an integrated analysis system of amplicons using retrovirus-mediated gene transfer coupled with a human full-length cDNA set. Applying this system to 17q12-21 amplicon observed in breast cancer, we identified GRB7 as a context-dependent oncogene, which modulates the ERBB2 signaling pathway through enhanced phosphorylation of ERBB2 and Akt. Our work provides an insight into the biological significance of gene amplification in human cancers.",
    keywords = "ERBB2, Expression screening, Gene amplification, GRB7, Tumorigenesis",
    author = "Makoto Saito and Yukiko Kato and Emi Ito and Jiro Fujimoto and Kosuke Ishikawa and Ayano Doi and Kentaro Kumazawa and Atsuka Matsui and Shiori Takebe and Takaomi Ishida and Sakura Azuma and Hiromi Mochizuki and Yoshifumi Kawamura and Yuka Yanagisawa and Reiko Honma and Imai, {Jun Ichi} and Hirokazu Ohbayashi and Naoki Goshima and Kentaro Senba and Shinya Watanabe",
    year = "2012",
    month = "6",
    day = "12",
    doi = "10.1016/j.febslet.2012.05.003",
    language = "English",
    volume = "586",
    pages = "1708--1714",
    journal = "FEBS Letters",
    issn = "0014-5793",
    publisher = "Elsevier",
    number = "12",

    }

    TY - JOUR

    T1 - Expression screening of 17q12-21 amplicon reveals GRB7 as an ERBB2-dependent oncogene

    AU - Saito, Makoto

    AU - Kato, Yukiko

    AU - Ito, Emi

    AU - Fujimoto, Jiro

    AU - Ishikawa, Kosuke

    AU - Doi, Ayano

    AU - Kumazawa, Kentaro

    AU - Matsui, Atsuka

    AU - Takebe, Shiori

    AU - Ishida, Takaomi

    AU - Azuma, Sakura

    AU - Mochizuki, Hiromi

    AU - Kawamura, Yoshifumi

    AU - Yanagisawa, Yuka

    AU - Honma, Reiko

    AU - Imai, Jun Ichi

    AU - Ohbayashi, Hirokazu

    AU - Goshima, Naoki

    AU - Senba, Kentaro

    AU - Watanabe, Shinya

    PY - 2012/6/12

    Y1 - 2012/6/12

    N2 - Gene amplification is a major genetic alteration in human cancers. Amplicons, amplified genomic regions, are believed to contain "driver" genes responsible for tumorigenesis. However, the significance of co-amplified genes has not been extensively studied. We have established an integrated analysis system of amplicons using retrovirus-mediated gene transfer coupled with a human full-length cDNA set. Applying this system to 17q12-21 amplicon observed in breast cancer, we identified GRB7 as a context-dependent oncogene, which modulates the ERBB2 signaling pathway through enhanced phosphorylation of ERBB2 and Akt. Our work provides an insight into the biological significance of gene amplification in human cancers.

    AB - Gene amplification is a major genetic alteration in human cancers. Amplicons, amplified genomic regions, are believed to contain "driver" genes responsible for tumorigenesis. However, the significance of co-amplified genes has not been extensively studied. We have established an integrated analysis system of amplicons using retrovirus-mediated gene transfer coupled with a human full-length cDNA set. Applying this system to 17q12-21 amplicon observed in breast cancer, we identified GRB7 as a context-dependent oncogene, which modulates the ERBB2 signaling pathway through enhanced phosphorylation of ERBB2 and Akt. Our work provides an insight into the biological significance of gene amplification in human cancers.

    KW - ERBB2

    KW - Expression screening

    KW - Gene amplification

    KW - GRB7

    KW - Tumorigenesis

    UR - http://www.scopus.com/inward/record.url?scp=84861963313&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=84861963313&partnerID=8YFLogxK

    U2 - 10.1016/j.febslet.2012.05.003

    DO - 10.1016/j.febslet.2012.05.003

    M3 - Article

    C2 - 22584052

    AN - SCOPUS:84861963313

    VL - 586

    SP - 1708

    EP - 1714

    JO - FEBS Letters

    JF - FEBS Letters

    SN - 0014-5793

    IS - 12

    ER -